← Back to Clinical Trials
Recruiting NCT07180498

NCT07180498 Evaluation of the Effect of Tea Tree and Chlorhexidine Mouthwashes on Healing After Third Molar Extraction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07180498
Status Recruiting
Phase
Sponsor Harran University
Condition Postoperative Pain
Study Type INTERVENTIONAL
Enrollment 54 participants
Start Date 2025-04-15
Primary Completion 2025-10-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Chlorhexidine Gluconate 0.12% MouthwashTea Tree Oil mouthwash

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 54 participants in total. It began in 2025-04-15 with a primary completion date of 2025-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this clinical study is to compare the effects of mouthwashes containing Chlorhexidine and tea tree oil on edema, pain, and trismus after the extraction of impacted third molars. Additionally, the effects on periodontal health will be examined by comparing the gum healing processes of patients using both mouthwashes.The main questions it aims to answer are: 1. Tea tree oil, said to have anti-inflammatory and antibacterial effects, could be an alternative to chlorhexidine in reducing postoperative complications after impacted tooth extraction. 2. Does tea tree oil, which has antimicrobial effects, have as positive an impact on periodontal health as chlorhexidine?Researchers will compare tea tree oil to chlorhexidine (routinely prescribed after the extraction of an impacted wisdom tooth) to see if tea tree oil works to decrease postoperative complications. Participants will: For 7 days after the operation, they will gargle with chlorhexidine mouthwash or mouthwash containing tea tree oil 3 times a day. They will come to the clinic for check-ups and measurements on the 2nd and 7th days after the operation. They will record their pain levels and the number of painkillers they take daily.

Eligibility Criteria

Inclusion Criteria: * Individuals undergoing extraction of Class 2, Class B mandibular third molars impacted in the lower jaw (Pell \& Gregory). * Individuals aged 18-65. * Individuals must be in stable general health (e.g., free of serious cardiovascular or kidney disease). * Individuals willing to use tea tree extract or other treatments. Exclusion Criteria: * Individuals with a known allergy or hypersensitivity to tea tree extract. * Individuals with serious illnesses such as heart failure or kidney disease. Patients with bleeding disorders. * Individuals during pregnancy and breastfeeding. * Individuals taking medications that may interact with tea tree extract (e.g., blood thinners or antihypertensives) * Individuals previously treated for edema. * Individuals with chronic edema.

Contact & Investigator

Central Contact

Mine alkaya karagoz

✉ minekaragoz@harran.edu.tr

📞 905365417606

Principal Investigator

Mine alkaya karagoz

PRINCIPAL INVESTIGATOR

Harran University

Frequently Asked Questions

Who can join the NCT07180498 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07180498 currently recruiting?

Yes, NCT07180498 is actively recruiting participants. Contact the research team at minekaragoz@harran.edu.tr for enrollment information.

Where is the NCT07180498 trial being conducted?

This trial is being conducted at Sanliurfa, Turkey (Türkiye).

Who is sponsoring the NCT07180498 clinical trial?

NCT07180498 is sponsored by Harran University. The principal investigator is Mine alkaya karagoz at Harran University. The trial plans to enroll 54 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology